Citations (62)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Irene Losada Galván, Julio Alonso-Padilla, Nuria Cortés-Serra, Cristina Alonso-Vega, Joaquim Gascón & María Jesús Pinazo. (2021) Benznidazole for the treatment of Chagas disease. Expert Review of Anti-infective Therapy 19:5, pages 547-556.
Read now
Read now
Juan M Bustamante & Rick L Tarleton. (2014) Potential new clinical therapies for Chagas disease. Expert Review of Clinical Pharmacology 7:3, pages 317-325.
Read now
Read now
Juan M Bustamante & Rick L Tarleton. (2011) Methodological advances in drug discovery for Chagas disease. Expert Opinion on Drug Discovery 6:6, pages 653-661.
Read now
Read now
Emmanuel Bottieau, Marc Vekemans & Alfons Van Gompel. (2011) Therapy of vector-borne protozoan infections in nonendemic settings. Expert Review of Anti-infective Therapy 9:5, pages 583-608.
Read now
Read now
Werner Apt. (2010) Current and developing therapeutic agents in the treatment of Chagas disease. Drug Design, Development and Therapy 4, pages 243-253.
Read now
Read now
Francisco Javier Carod-Artal. (2010) Trypanosomiasis, cardiomyopathy and the risk of ischemic stroke. Expert Review of Cardiovascular Therapy 8:5, pages 717-728.
Read now
Read now
Jason Bowling & Elizabeth A Walter. (2009) Recognizing and meeting the challenge of Chagas disease in the USA. Expert Review of Anti-infective Therapy 7:10, pages 1223-1234.
Read now
Read now
Rodolfo Viotti, Carlos Vigliano, Bruno Lococo, Maria Gabriela Alvarez, Marcos Petti, Graciela Bertocchi & Alejandro Armenti. (2009) Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities. Expert Review of Anti-infective Therapy 7:2, pages 157-163.
Read now
Read now
Maria Nazaré C Soeiro & Solange L de Castro. (2009) Trypanosoma cruzi targets for new chemotherapeutic approaches. Expert Opinion on Therapeutic Targets 13:1, pages 105-121.
Read now
Read now
Articles from other publishers (53)
Iván Beltran-Hortelano, Verónica Alcolea, María Font & Silvia Pérez-Silanes. (2022) Examination of multiple Trypanosoma cruzi targets in a new drug discovery approach for Chagas disease. Bioorganic & Medicinal Chemistry 58, pages 116577.
Crossref
Crossref
David Vizcaya, Ulrike Grossmann, Frank Kleinjung, Ruiping Zhang, Kiliana Suzart-Woischnik, Sandra Seu, Teresa Ramirez, Leylen Colmegna & Oscar Ledesma. (2021) Serological response to nifurtimox in adult patients with chronic Chagas disease: An observational comparative study in Argentina. PLOS Neglected Tropical Diseases 15:10, pages e0009801.
Crossref
Crossref
Chen Chao, José L. Leone & Carlos A. Vigliano. (2020) Chagas disease: Historic perspective. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1866:5, pages 165689.
Crossref
Crossref
Ana Cláudia Alvarenga Carneiro, G.P. Costa, Cyntia Silva Ferreira, Isalira Peroba Rezende Ramos, Mariáurea Matias Sarandy, Ana Luísa Junqueira Leite, A.P.J. Menezes, B.M. Silva, K.O.P.C. Nogueira, A.C.C. Carvalho, Reggiani Vilela Gonçalves & André Talvani. (2020) Combination therapy with benznidazole and doxycycline shows no additive effect to monotherapy with benznidazole in mice infected with the VL-10 strain of the Trypanosoma cruzi. International Journal of Cardiology 299, pages 243-248.
Crossref
Crossref
Julio A. Urbina. 2020. Chagas Disease. Chagas Disease
123
144
.
Samanta Moroni, Maria Elena Marson, Guillermo Moscatelli, Guido Mastrantonio, Margarita Bisio, Nicolas Gonzalez, Griselda Ballering, Jaime Altcheh & Facundo García-Bournissen. (2019) Negligible exposure to nifurtimox through breast milk during maternal treatment for Chagas Disease. PLOS Neglected Tropical Diseases 13:8, pages e0007647.
Crossref
Crossref
Héctor Freilij. 2019. Chagas Disease. Chagas Disease
3
22
.
María Elena Villagran-Herrera, José Alejandro Martínez-Ibarra, Manuel Sánchez-Moreno, Hebert Luis Hernández-Montiel, Ricardo Francisco Mercado-Curiel, Nicolás Camacho-Calderón & José Antonio de Diego-Cabrera. 2018. Chagas Disease - Basic Investigations and Challenges. Chagas Disease - Basic Investigations and Challenges.
Julio A Urbina. (2018) The long road towards a safe and effective treatment of chronic Chagas disease. The Lancet Infectious Diseases 18:4, pages 363-365.
Crossref
Crossref
Jaime Franco, Laura Scarone & Marcelo A. Comini. 2018. Neglected Diseases: Extensive Space for Modern Drug Discovery. Neglected Diseases: Extensive Space for Modern Drug Discovery
97
133
.
Claudia Magalhaes Calvet, Jun Yong Choi, Diane Thomas, Brian Suzuki, Ken Hirata, Sharon Lostracco-Johnson, Liliane Batista de Mesquita, Alanderson Nogueira, Marcelo Meuser-Batista, Tatiana Araujo Silva, Jair Lage Siqueira-Neto, William R. Roush, Mirian Claudia de Souza Pereira, James H. McKerrow & Larissa M. Podust. (2017) 4-aminopyridyl-based lead compounds targeting CYP51 prevent spontaneous parasite relapse in a chronic model and improve cardiac pathology in an acute model of Trypanosoma cruzi infection. PLOS Neglected Tropical Diseases 11:12, pages e0006132.
Crossref
Crossref
María G. Álvarez, Carlos Vigliano, Bruno Lococo, Graciela Bertocchi & Rodolfo Viotti. (2017) Prevention of congenital Chagas disease by Benznidazole treatment in reproductive-age women. An observational study. Acta Tropica 174, pages 149-152.
Crossref
Crossref
Glaucia Vilar-Pereira, Isabela Resende Pereira, Leonardo Alexandre de Souza Ruivo, Otacilio Cruz Moreira, Andrea Alice da Silva, Constança Britto & Joseli Lannes-Vieira. (2016) Combination Chemotherapy with Suboptimal Doses of Benznidazole and Pentoxifylline Sustains Partial Reversion of Experimental Chagas' Heart Disease. Antimicrobial Agents and Chemotherapy 60:7, pages 4297-4309.
Crossref
Crossref
. (2016) Benznidazole for Chronic Chagas’ Cardiomyopathy. New England Journal of Medicine 374:2, pages 188-190.
Crossref
Crossref
Francisco Cordeiro-Barbosa, Fernando Oréfice & Daniel Vítor Vasconcelos-Santos. 2016. Intraocular Inflammation. Intraocular Inflammation
1413
1417
.
Julio A. Urbina & James H. McKerrow. (2015) Drug Susceptibility of Genetically Engineered Trypanosoma cruzi Strains and Sterile Cure in Animal Models as a Criterion for Potential Clinical Efficacy of Anti-T. cruzi Drugs. Antimicrobial Agents and Chemotherapy 59:12, pages 7923-7924.
Crossref
Crossref
Deena Shrestha, Arlete Rita Penitente, Aline Luciano Horta, Ana Luísa Junqueira Leite, Clóvis A. Neves, Antônio J. Natali, Guilherme de Paula Costa & Andre Talvani. (2015) Enalapril in Combination with Benznidazole Reduces Cardiac Inflammation and Creatine Kinases in Mice Chronically Infected with Trypanosoma cruzi. The American Journal of Tropical Medicine and Hygiene 93:5, pages 976-982.
Crossref
Crossref
M. Silvina Lo Presti, P. Carolina Bazán, Mariana Strauss, Alejandra L. Báez, H. Walter Rivarola & Patricia A. Paglini-Oliva. (2015) Trypanothione reductase inhibitors: Overview of the action of thioridazine in different stages of Chagas disease. Acta Tropica 145, pages 79-87.
Crossref
Crossref
Maria Jose Morilla & Eder Lilia Romero. (2015) Nanomedicines against Chagas disease: an update on therapeutics, prophylaxis and diagnosis. Nanomedicine 10:3, pages 465-481.
Crossref
Crossref
Facundo García-Bournissen, Samanta Moroni, Maria Elena Marson, Guillermo Moscatelli, Guido Mastrantonio, Margarita Bisio, Laura Cornou, Griselda Ballering & Jaime Altcheh. (2015) Limited infant exposure to benznidazole through breast milk during maternal treatment for Chagas disease. Archives of Disease in Childhood 100:1, pages 90-94.
Crossref
Crossref
Julio A. Urbina. (2015) Recent Clinical Trials for the Etiological Treatment of Chronic Chagas Disease: Advances, Challenges and Perspectives. Journal of Eukaryotic Microbiology 62:1, pages 149-156.
Crossref
Crossref
Jaime Altcheh, Guillermo Moscatelli, Guido Mastrantonio, Samanta Moroni, Norberto Giglio, Maria Elena Marson, Griselda Ballering, Margarita Bisio, Gideon Koren & Facundo García-Bournissen. (2014) Population Pharmacokinetic Study of Benznidazole in Pediatric Chagas Disease Suggests Efficacy despite Lower Plasma Concentrations than in Adults. PLoS Neglected Tropical Diseases 8:5, pages e2907.
Crossref
Crossref
R. Viotti, B. Alarcón de Noya, T. Araujo-Jorge, M. J. Grijalva, F. Guhl, M. C. López, J. M. Ramsey, I. Ribeiro, A. G. Schijman, S. Sosa-Estani, F. Torrico & J. Gascon. (2014) Towards a Paradigm Shift in the Treatment of Chronic Chagas Disease. Antimicrobial Agents and Chemotherapy 58:2, pages 635-639.
Crossref
Crossref
Francisco Javier Carod Artal. 2014. Meningitis, encefalitis y otras infecciones del SNC. Meningitis, encefalitis y otras infecciones del SNC
253
288
.
Graciela L. Bertocchi, Carlos A. Vigliano, Bruno G. Lococo, Marcos A. Petti & Rodolfo J. Viotti. (2013) Clinical characteristics and outcome of 107 adult patients with chronic Chagas disease and parasitological cure criteria. Transactions of The Royal Society of Tropical Medicine and Hygiene 107:6, pages 372-376.
Crossref
Crossref
Julio A. Urbina. 2013. Trypanosomatid Diseases. Trypanosomatid Diseases
489
514
.
D. E. Perez-Mazliah, M. G. Alvarez, G. Cooley, B. E. Lococo, G. Bertocchi, M. Petti, M. C. Albareda, A. H. Armenti, R. L. Tarleton, S. A. Laucella & R. Viotti. (2012) Sequential combined treatment with allopurinol and benznidazole in the chronic phase of Trypanosoma cruzi infection: a pilot study. Journal of Antimicrobial Chemotherapy 68:2, pages 424-437.
Crossref
Crossref
Francisco Javier Carod-Artal. 2013. Neuroparasitology and Tropical Neurology. Neuroparasitology and Tropical Neurology
103
123
.
Roberta Lattes, Laura Linares & Marcelo Radisic. (2012) Emerging Parasitic Infections in Transplantation. Current Infectious Disease Reports 14:6, pages 642-649.
Crossref
Crossref
Rick L. Tarleton & James W. Curran. (2012) Is Chagas Disease Really the “New HIV/AIDS of the Americas”?. PLoS Neglected Tropical Diseases 6:10, pages e1861.
Crossref
Crossref
Antonio L. Ribeiro, Maria P. Nunes, Mauro M. Teixeira & Manoel O. C. Rocha. (2012) Diagnosis and management of Chagas disease and cardiomyopathy. Nature Reviews Cardiology 9:10, pages 576-589.
Crossref
Crossref
Samar N. El-Beshbishi, Nairmen N. Ahmed, Samar H. Mostafa & Goman A. El-Ganainy. (2011) Parasitic infections and myositis. Parasitology Research 110:1, pages 1-18.
Crossref
Crossref
Rodolfo Viotti, Carlos Vigliano, María Gabriela Álvarez, Bruno Lococo, Marcos Petti, Graciela Bertocchi, Alejandro Armenti, Ana María De Rissio, Gretchen Cooley, Rick Tarleton & Susana Laucella. (2011) Impact of Aetiological Treatment on Conventional and Multiplex Serology in Chronic Chagas Disease. PLoS Neglected Tropical Diseases 5:9, pages e1314.
Crossref
Crossref
Cristiane Menezes, Germano Carneiro Costa, Kenneth J. Gollob & Walderez O. Dutra. (2011) Clinical aspects of Chagas disease and implications for novel therapies. Drug Development Research 72:6, pages 471-479.
Crossref
Crossref
Solange L. de Castro, Denise G. J. Batista, Marcos M. Batista, Wanderson Batista, Anissa Daliry, Elen M. de Souza, Rubem F. S. Menna-Barreto, Gabriel M. Oliveira, Kelly Salomão, Cristiane F. Silva, Patricia B. Silva & Maria de Nazaré C. Soeiro. (2011)
Experimental Chemotherapy for Chagas Disease: A Morphological, Biochemical, and Proteomic Overview of Potential
Trypanosoma cruzi
Targets of Amidines Derivatives and Naphthoquinones
. Molecular Biology International 2011, pages 1-13.
Crossref
Crossref
Michal Svoboda, Myrna Virreira, Carine Truyens, Faustino Torrico & Yves Carlier. 2011. Molecular Microbiology. Molecular Microbiology
713
725
.
Jaime Altcheh, Guillermo Moscatelli, Samanta Moroni, Facundo Garcia-Bournissen & Hector Freilij. (2011) Adverse Events After the Use of Benznidazole in Infants and Children With Chagas Disease. Pediatrics 127:1, pages e212-e218.
Crossref
Crossref
. (2010) Chagas' Disease and Solid Organ Transplantation. Transplantation Proceedings 42:9, pages 3354-3359.
Crossref
Crossref
François-Xavier Lescure, Guillaume Le Loup, Hector Freilij, Michel Develoux, Luc Paris, Laurent Brutus & Gilles Pialoux. (2010) Chagas disease: changes in knowledge and management. The Lancet Infectious Diseases 10:8, pages 556-570.
Crossref
Crossref
Julio A. Urbina. (2010) Specific chemotherapy of Chagas disease: Relevance, current limitations and new approaches. Acta Tropica 115:1-2, pages 55-68.
Crossref
Crossref
Alexander J. McADam & Arlene H. Sharpe. 2010. Robbins and Cotran Pathologic Basis of Disease. Robbins and Cotran Pathologic Basis of Disease
331
398
.
C.N. Kotton & R. Lattes. (2009) Parasitic Infections in Solid Organ Transplant Recipients. American Journal of Transplantation 9, pages S234-S251.
Crossref
Crossref
Guillaume Le Loup, Francois-Xavier Lescure, Michel Develoux & Gilles Pialoux. (2009) Maladie de Chagas : formes cliniques et prise en charge en zone non endémique. La Presse Médicale 38:11, pages 1654-1666.
Crossref
Crossref
Rodolfo Viotti, Carlos Vigliano & Alejandro Armenti. (2009) Nothing Goes on Forever...Chagas Disease. Revista Española de Cardiología (English Edition) 62:11, pages 1332-1333.
Crossref
Crossref
Rodolfo Viotti, Carlos A. Vigliano, María G. Álvarez, Bruno E. Lococo, Marcos A. Petti, Graciela L. Bertocchi & Alejandro H. Armenti. (2009) The Impact of Socioeconomic Conditions on Chronic Chagas Disease Progression. Revista Española de Cardiología (English Edition) 62:11, pages 1224-1232.
Crossref
Crossref
Rodolfo Viotti, Carlos Vigliano & Alejandro Armenti. (2009) No hay mal que cien años dure… el mal de Chagas. Revista Española de Cardiología 62:11, pages 1332-1333.
Crossref
Crossref
Rodolfo Viotti, Carlos A. Vigliano, María G. Álvarez, Bruno E. Lococo, Marcos A. Petti, Graciela L. Bertocchi & Alejandro H. Armenti. (2009) El impacto de las condiciones socioeconómicas en la evolución de la enfermedad de Chagas crónica. Revista Española de Cardiología 62:11, pages 1224-1232.
Crossref
Crossref
Michele Gabriele de Oliveira Pacheco, Cristiane França da Silva, Elen Mello de Souza, Marcos Meuser Batista, Patrícia Bernardino da Silva, Arvind Kumar, Chad E. Stephens, David W. Boykin & Maria de Nazaré C. Soeiro. (2009) Trypanosoma cruzi: Activity of heterocyclic cationic molecules in vitro. Experimental Parasitology 123:1, pages 73-80.
Crossref
Crossref
Julio A Urbina. (2009) Ergosterol biosynthesis and drug development for Chagas disease. Memórias do Instituto Oswaldo Cruz 104:suppl 1, pages 311-318.
Crossref
Crossref
Mario Fernández-Ruiz & Francisco López-Medrano. (2009) Implicaciones diagnósticas y terapéuticas de la enfermedad de Chagas en España. Medicina Clínica 133:3, pages 117-118.
Crossref
Crossref
Caryn Bern, Susan P Montgomery, Louis Katz, Sally Caglioti & Susan L Stramer. (2008) Chagas disease and the US blood supply. Current Opinion in Infectious Diseases 21:5, pages 476-482.
Crossref
Crossref
Johannes A Blum, Michael J Zellweger, Christian Burri & Christoph Hatz. (2008) Cardiac involvement in African and American trypanosomiasis. The Lancet Infectious Diseases 8:10, pages 631-641.
Crossref
Crossref
Paola Carolina Bazán, María Silvina Lo Presti, Héctor Walter Rivarola, María Fernanda Triquell, Ricardo Fretes, Alicia Ruth Fernández, Julio Enders & Patricia Paglini-Oliva. (2008) Chemotherapy of chronic indeterminate Chagas disease: a novel approach to treatment. Parasitology Research 103:3, pages 663-669.
Crossref
Crossref